Assessment of hypokalemia and clinical prognosis in Patients with COVID-19 in Yangzhou, China

Abstract

Background Hypokalemia is a frequent electrolyte imbalance in patients with COVID-19. The aim of this study was to estimate the association between hypokalemia and clinical prognosis in patients with moderate COVID-19. Methods A single-center, retrospective, observational study was conducted on 81 non-ICU admitted patients with moderate COVID-19 according to the criteria issued by the Chinese Health Bureau in the Third People’s Hospital of Yangzhou (Northern Jiangsu People’s Hospital New District Branch) from 4th to 25th August 2021. The demographic, clinical, and laboratory data were reviewed and collected, then the correlation between hypokalemia and prognosis was determined. Results The level of serum potassium of patients ranged from 2.80 mmol/L to 4.70 mmol/L. Hypokalemia was detected in 39 out of the 81 included patients (48.15%) during hospitalization. Patients with hypokalemia had prolonged days of negative nucleic acid conversion and hospital stay. Correlation analysis showed that the level of serum potassium was negatively correlated with days of negative nucleic acid conversion and length of hospital stay. Bivariate logistic regression analysis proved that hypokalemia was a risk factor for prolonged hospital stay in patients with moderate COVID-19. Conclusion Hypokalemia was prevalent in patients with moderate COVID-19 in Yangzhou, China. Hypokalemia was associated with the prolonged hospital stay in patients with moderate COVID-19.

Approaching Personalized Medicine: The Use of Machine Learning to Determine Predictors of Mortality in a Population with SARS-CoV-2 Infection

“…Interestingly, hypokalemia has also been shown to be an indicator of a poorer prognosis and longer days of negative nucleic acid conversion. It is thought that this may be due to the fact that the virus interferes with ACE2, a key factor in the enzymatic cascades that maintain adequate levels of potassium in cells, causing the dysregulation of cellular physiological activity [51]. This disruption of cellular physiological systems also appears to cause the dysregulation of electrolyte homeostasis and pH imbalance [52].…”

Associations between laboratory variables and clinical features in patients hospitalized with COVID-19 after non-mRNA vaccination in China: A cross-sectional study

“…Electrolyte imbalance can be used as a marker of poor prognosis for COVID-19 [ 37 ]. Data from Jiangtao Yin et al showed patients with hypokalemia are more likely to have prolonged TNPT and days of hospitalization [ 38 ]. The serum potassium might affect body temperature and thus extended time in hospital for symptomatic treatment.…”

Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study

“…The study outcome was ascertained through the presence of diagnostic codes or laboratory data, based on clinical guidelines and previous studies [ 8 , 24 , 25 ]. International Classification of Diseases 10th Revision (ICD-10) code E87.6 was used to identify cases of hypokalemia from in- or outpatient data.…”